Fierce Pharma

AUGUST 8, 2023

Novo Nordisk has been riding the momentum of weight loss drug Wegovy ever since it stormed onto the market in 2021, creating widespread hype and even some supply shortfalls. | In a large phase 3 trial, Wegovy cut the risk of major adverse cardiovascular events by 20% compared with placebo and standard of care, Novo said Tuesday. Specifically, investigators measured Wegovy's 2.4-mg dose for its ability to cut the risk of a cardio death, heart attack or stroke.

Marketing 232

Marketing 232

PharmExec

AUGUST 8, 2023

The precision of programmatic advertising is reshaping the way life sciences brands engage with healthcare professionals, offering enhanced personalization, scale, and optimization in today's digital landscape.

Healthcare 98

Healthcare Healthcare 98

Fierce Pharma

AUGUST 8, 2023

It took Bayer’s new CEO Bill Anderson about 20 seconds into his first quarterly conference call to go against the grain. | In his first quarterly earnings call since taking over as CEO at Bayer, Bill Anderson faced several questions about the structure of the company. He said to stay tuned until early 2024. The company reported a 14% decline in revenue for the quarter, with all three business sectors seeing a drop in sales.

Sales 232

Sales 232

PharmaTech

AUGUST 8, 2023

Catalent's Martin De Brauwere and Maria Lopez react to cell therapy innovations and highlight strategies to optimize the drug development and manufacturing process with assistance from a CDMO.

Manufacturing 98

Manufacturing 98

Advertisement

Distribution

Fierce Pharma

AUGUST 8, 2023

Big changes are brewing at Emergent BioSolutions, as the beleaguered contract manufacturer puts its CDMO business on the back burner in a bid to shore up its core medical countermeasures and Narcan | Emergent is de-emphasizing its focus on its CDMO services business. As part of the move, Emergent will scale back operations at its Bayview facility in Baltimore, Maryland, as well as its plants in Canton, Massachusetts, and Rockville, Maryland.

Manufacturing 215

Manufacturing Medical 215

European Pharmaceutical Review

AUGUST 8, 2023

Headline results from Novo Nordisk’s “landmark” SELECT trial in cardiovascular outcomes has demonstrated a 20 percent reduction in major adverse cardiovascular events (MACEs) for semaglutide 2.4mg (Wegovy ® ) compared to a placebo. “People living with obesity have an increased risk of cardiovascular disease but to date, there are no approved weight management medications proven to deliver effective weight management while also reducing the risk of heart attack, stroke or cardio

Management 97

Management Patients Medical Pharmaceutical 97

PharmaVoice

AUGUST 8, 2023

Ozempic and Wegovy have become household names for weight loss. But obesity is complex, and Phenomix Sciences is looking to bring a personalized medicine approach to the field.

Medicine 97

Medicine 97

Fierce Pharma

AUGUST 8, 2023

After closing shop in Europe two years ago, bluebird bio still aims to become an industry-leading gene therapy maker in the U.S. | Bluebird aims to become an industry-leading gene therapy maker. First, it’s hoping new launches will help keep its doors open over the next 12 months.

Leads 186

Leads FDA 186

MedCity News

AUGUST 8, 2023

HHS issued an alert warning providers about Rhysida, a ransomware gang that recently begun launching attacks on healthcare organizations. The group deploys its ransomware primarily through phishing attacks or the exploitation of legitimate cybersecurity tools.

Healthcare 95

Healthcare Healthcare 95

Fierce Pharma

AUGUST 8, 2023

As Eli Lilly's diabetes star Mounjaro skyrockets in growth and races toward a potential obesity indication, the company isn't phased by supply strains or new trial results from Novo Nordisk's estab | Eli Lilly expects supply strains for popular diabetes med Mounjaro to let up next year. And the Indianapolis pharma isn't deterred by new trial results from rival Novo Nordisk's Wegovy, which could boast a cardiovascular edge.

Sales 175

Sales Pharma 175

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

AUGUST 8, 2023

Novo Nordisk weight-loss drug Wegovy reduced the risk of major cardiovascular events by 20% in a large clinical trial. The company said the results support expanding the drug’s label, but the looming question is whether the data will persuade payers to cover the pricey chronic therapy.

Biopharma 94

Biopharma Pharma 94

Medgadget

AUGUST 8, 2023

EarliTec Dx , a medtech company based in Georgia, has developed the EarliPoint Evaluation System for Autism Spectrum Disorder (ASD). This common neurodevelopmental condition is often overlooked in affected children, leading to a lack of early intervention and care. Part of the issue is a lack of access to specialists who can diagnose the condition. Another issue is the lack of quantitative tools that can assist clinicians in diagnosing ASD, and instead they rely on subjective measurements and ob

Healthcare Provider 88

Healthcare Provider Healthcare Healthcare Prescription 88

MedCity News

AUGUST 8, 2023

Daybreak Health — a startup that partners with school districts to provide children with virtual mental health services — recently closed a $13 million Series B funding round. The company has partnered with more than 60 public school districts since it began providing care in 2019.

90

90

Pharmaceutical Technology

AUGUST 8, 2023

Jacobio Pharma received breakthrough therapy designation (BTD) for glecirasib to treat pancreatic cancer patients with the KRAS G12C mutation.

Pharma 98

Pharma Patients 98

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

AUGUST 8, 2023

“Botched math” in calculating clinical data for an autoimmune disease drug is one of the allegations Nektar Therapeutics makes in a legal complaint against Eli Lilly. The biotech claims its former partner tried to disadvantage the asset in order to advance development of another drug it acquired in a billion dollar deal.

Pharma 87

Pharma Biopharma 87

Pharmaceutical Technology

AUGUST 8, 2023

An increasing amount of information make artificial intelligence (AI) stand out as a promising solution to improve the provision of healthcare.

Healthcare 98

Healthcare Healthcare 98

European Pharmaceutical Review

AUGUST 8, 2023

Two of AstraZeneca’s key medicines have been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC). Tom Keith-Roach, President of AstraZeneca UK announced: “We are pleased that the SMC has now accepted Forxiga (dapagliflozin) for use in patients with chronic heart failure with preserved or mildly reduced ejection fraction and Tezspire (tezepelumab) has been accepted for restricted use in severe asthma within NHS Scotland.

Medicine 85

Medicine Patients Pharmaceutical 85

Pharmaceutical Technology

AUGUST 8, 2023

As part of the agreement, Astellas will have exclusive negotiation and first refusal for licencing P-MUC1C-ALLO1 in solid tumours.

98

98

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Medgadget

AUGUST 8, 2023

Researchers at ETH Zurich have developed a bacteriophage system to identify and treat bacterial bladder infections. Bacteriophages are viruses that infect bacteria, but these microorganisms have fallen out of favor as a treatment method for infection since antibiotics came along. Well, antibiotics are looking increasingly shaky as bacteria evolve to resist them, so researchers are returning to bacteriophages as a way to treat antibiotic-resistant infections.

Engineering 82

Engineering Patients Medicine 82

Copyright Clearance Center

AUGUST 8, 2023

The post Will Building LLMs Become the New Revenue Driver for Academic Publishing? appeared first on Copyright Clearance Center.

98

98

MedCity News

AUGUST 8, 2023

Through Scripta Insights’ app, members of its customers can input the medications they’re taking, and the company will provide a savings report that will show different options on how they can save on their prescriptions. Starting in 2024, Cost Plus Drugs may show up as an option in the savings report.

Prescription 81

Prescription Medical 81

Medgadget

AUGUST 8, 2023

Engineers at the Technical University of Munich in Germany have developed a system that allows them to semi automate the production of tactile sensors. Such sensors can provide robotic systems, such as robotic prostheses, with a sense of compression and tension with regard to the objects and surfaces they come in contact with. Most robotic systems have integrated sensors, but this design allows researchers to create sensors for a variety of arbitrary surfaces, and then just wrap them around the

Manufacturing 74

Manufacturing Electronics Engineering Medical 74

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

MedCity News

AUGUST 8, 2023

About 27% of Medicare Advantage enrollees are Black, Latino or Asian, versus 17% of traditional Medicare enrollees, according to a report conducted by ATI Advisory and commissioned by the Better Medicare Alliance.

79

79

Pharmaceutical Commerce

AUGUST 8, 2023

As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.

Pharma 87

Pharma 87

PharmaTimes

AUGUST 8, 2023

Tezspire is a drug for severe asthma and Forxiga is used to treat chronic heart failure - News - PharmaTimes

81

81

Referral MD

AUGUST 8, 2023

Photo by Daniele Franchi on Unsplash Good healthcare marketing is essential for the growth of any business, and the healthcare/medical practice is no exception. With around 30 new patients every month required to grow a practice, building a practice offering high-quality services at reasonable prices is essential to achieve this target. While there are several established marketing techniques and referral programs, there are also several other ways healthcare practitioners can use to grow their

Marketing 59

Marketing Healthcare Healthcare Media 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmaTimes

AUGUST 8, 2023

Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response - News - PharmaTimes

76

76

Pharmaceutical Technology

AUGUST 8, 2023

Pricing and reimbursement of pharmaceuticals is changing in Sweden, with prices lower than average as a result of growing cost containment strategies. Here’s what you need to know.

Marketing 52

Marketing Pharmaceutical 52

Spotio

AUGUST 8, 2023

Running a solar business without solar design software is becoming increasingly difficult. Once you add this kind of tool to your company’s tech stack, you’ll be able to create more accurate solar designs, lower operational costs, and better comply with regulations. Of course, not every app in this category is created equal. So, the question is, what’s the best solar design software on the market?

Sales 52

Sales Engineering Prospecting Marketing 52

Evolve Your Success

AUGUST 8, 2023

Success in cardiovascular sales isn’t just about numbers; it’s about changing lives, one heartbeat at a time. In this inspiring episode, Samuel Adeyinka sits down with Alex Matthews to dive deep into the world of cardiovascular device sales. Alex shares his remarkable journey, shedding light on the challenges and triumphs of being a sales rep in the fast-paced and impactful cardiovascular space.

Sales 52

Sales Medical Management Patients 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management